Renal Osteodystrophy and Bone Biopsy
By:
Ana Carina Ferreira Nephrology Department – Hospital Curry Cabral, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal
NOVA Medical School – Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Ana Carina Ferreira in
Current site
Google Scholar
PubMed Close
and
Aníbal Ferreira Nephrology Department – Hospital Curry Cabral, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal
NOVA Medical School – Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Aníbal Ferreira in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 22: Issue 1
Published Online:
Apr 2023
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 22: Issue 1 (Apr 2023): Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
Copyright © 2023 by the American Society of Nephrology 2023
Page Count:
7
Article Category:
Research Article
Print Publication Date:
01 Apr 2023
Published Online:
Apr 2023
  • 1.

    Cannata-Andía JB, Martín-Carro B, Martín-Vírgala J, Rodríguez-Carrio J, Bande-Fernández JJ, Alonso-Montes C, et al.: Chronic kidney disease-mineral and bone disorders: Pathogenesis and management. Calcif Tissue Int 108: 410–422, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al.: Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What’s changed and why it matters. Kidney Int 92: 26–36, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al.; Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 69: 1945–1953, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Nickolas TL: The quest for better biomarkers of bone turnover in CKD. J Am Soc Nephrol 29: 1353–1355, 2018 PubMed

  • 5.

    Evenepoel P, D’Haese P, Bacchetta J, Cannata-Andia J, Ferreira A, Haarhaus M, et al.; ERA-EDTA Working Group on CKD-MBD: Bone biopsy practice patterns across Europe: The European renal osteodystrophy initiative-a position paper. Nephrol Dial Transplant 32: 1608–1613, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Ferreira AC, Cohen-Solal M, D’Haese PC, Ferreira A; European Renal Osteodystrophy (EUROD), an initiative of the CKD-MBD working group of the ERA-EDTA: The role of bone biopsy in the management of CKD-MBD. Calcif Tissue Int 108: 528–538, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Ott SM: Renal osteodystrophy-time for common nomenclature. Curr Osteoporos Rep 15: 187–193, 2017 PubMed

  • 8.

    Ott SM. Histomorphometric measurements of bone turnover, mineralization, and volume. Clin J Am Soc Nephrol 3 Suppl 3: S151–S156, 2008

  • 9.

    Delaisse JM, Andersen TL, Kristensen HB, Jensen PR, Andreasen CM, Søe K: Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone 141: 115628, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Kakani E, Elyamny M, Ayach T, El-Husseini A: Pathogenesis and management of vascular calcification in CKD and dialysis patients. Semin Dial 32: 553–561, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208–2218, 2004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Block GA, Chertow GM, Cooper K, Xing S, Fouqueray B, Halperin M, et al.: Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial. Hemodial Int 25: 78–85, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M: Fractures in patients with CKD-diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92: 1343–1355, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Pimentel A, Ureña-Torres P, Bover J, Luis Fernandez-Martín J, Cohen-Solal M: Bone fragility fractures in CKD patients. Calcif Tissue Int 108: 539–550, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, et al.: High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85: 166–173, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Haarhaus M, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA): Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int 100: 546–558, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Hernandes FR, Canziani ME, Barreto FC, Santos RO, Moreira VM, Rochitte CE, et al.: The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study. PLoS One 12: e0174811, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Neto R, Pereira L, Magalhães J, Quelhas-Santos J, Frazão J: Low bone turnover is associated with plain X-ray vascular calcification in predialysis patients. PLoS One 16: e0258284, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Ferreira AC, Cotovio P, Aires I, Mendes M, Navarro D, Silva C, et al.: The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients. Calcif Tissue Int 110: 215–224, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Ferreira AC, Mendes M, Silva C, Cotovio P, Aires I, Navarro D, et al.: Improvement of mineral and bone disorders after renal transplantation. Transplantation 106: e251–e261, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Kim DW, Hwang SY, Nam YJ, Kim D, Shin SJ, Yoon HE: The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease. Nutr Metab Cardiovasc Dis 30: 1476–1483, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Carbonara CEM, Reis LMD, Quadros KRDS, Roza NAV, Sano R, Carvalho AB, et al.: Renal osteodystrophy and clinical outcomes: Data from the Brazilian Registry of Bone Biopsies - REBRABO. J Bras Nefrol 42: 138–146, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Novel-Catin E, Pelletier S, Fouque D, Roux JP, Chapurlat R, D’Haese P, et al.: Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples. Bone 138: 115460, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Steller Wagner Martins C, Jorgetti V, Moysés RMA: Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 27: 243–250, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, et al.: Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone 152: 116066, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Salam S, Gallagher O, Hughes D, Khwaja A, Eastell R: The role of static bone histomorphometry in diagnosing renal osteodystrophy. Bone 142: 115689, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Jørgensen HS, Ferreira AC, D’Haese P, Haarhaus M, Vervloet M, Lafage-Proust MH, et al.; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease - Mineral and Bone Disorder Working Group (CKD-MBD WG): Bone histomorphometry for the diagnosis of renal osteodystrophy: A call for harmonization of reference ranges. Kidney Int 102: 431–434, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    El-Husseini A, Nagy E, Barreto FC: Is bone histomorphometry required for assessment of renal osteodystrophy in clinical practice? Kidney Int 102: 670, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Soeiro EMD, Castro L, Menezes R, Elias RM, Dos Reis LM, Jorgetti V, et al.: Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: Effect of age, gender, and race. Pediatr Nephrol 35: 1297–1305, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Bhan A, Qiu S, Rao SD: Bone histomorphometry in the evaluation of osteomalacia. Bone Rep 8: 125–134, 2018 PubMed

  • 31.

    Keronen S, Martola L, Finne P, Burton IS, Kröger H, Honkanen E: Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol 14: 894–903, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, et al.: A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol 30: 355–365, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Evenepoel P, Behets GJ, Viaene L, D’Haese PC: Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney Int 91: 469–476, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Vavanikunnel J, Sewing L, Triantafyllidou M, Steighardt A, Baumann S, Egger A, et al.: Determinants of low bone turnover in type 2 diabetes—The role of PTH. Calcif Tissue Int 111: 587–596, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P: Biochemical markers of bone turnover in diabetes patients—A meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25: 1697–1708, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Starup-Linde J, Vestergaard P: Biochemical bone turnover markers in diabetes mellitus—a systematic review. Bone 82: 69–78, 2016 PubMed

  • 37.

    Wittrant Y, Gorin Y, Woodruff K, Horn D, Abboud HE, Mohan S, et al.: High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 42: 1122–1130, 2008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Pereira L, Magalhães J, Mendonça L, Neto R, Santos J, Carvalho CG, et al.: Evaluation of renal osteodystrophy and serum bone-related biomarkers in a peritoneal dialysis population. J Bone Miner Res 37: 1689–1699, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Keronen SM, Martola LAL, Finne P, Burton IS, Tong XF, Kröger HP, et al.: Clinical prediction of high-turnover bone disease after kidney transplantation. Calcif Tissue Int 110: 324–333, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Jørgensen H, Behets G, Bammens B, Claes K, Meijers B, Naesens M, et al.: Natural history of bone disease following kidney transplantation. J Am Soc Nephrol 33: 638–652, 2022.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Kidney Disease: Improving Global Outcomes CKDMBDUWG. KDIGO 2017 Clinical Practice Guideline Update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7: 1–59, 2017 PubMed

    • PubMed
    • Export Citation
  • 42.

    Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R: Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol 29: 1557–1565, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, et al.: Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67: 559–566, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Nickolas TL, Chen N, McMahon DJ, Dempster D, Zhou H, Dominguez J 2nd, et al.: A microRNA approach to discriminate cortical low bone turnover in renal osteodystrophy. JBMR Plus 4: e10353, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Pichone A, Gomes CP, Lima LFC, Moreira CA, Paranhos-Neto FP, Madeira M, et al.: Assessment of trabecular and cortical parameters using high-resolution peripheral quantitative computed tomography, histomorphometry and microCT of iliac crest bone core in hemodialysis patients. Bone Rep 16: 101173, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Aaltonen L, Koivuviita N, Seppänen M, Tong X, Kröger H, Löyttyniemi E, et al.: Correlation between 18F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone 134: 115267, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Blake GM, Puri T, Siddique M, Frost ML, Moore AEB, Fogelman I: Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. Quant Imaging Med Surg 8: 47–59, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Ott SM, Malluche HH, Jorgetti V, Elder GJ: Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. Kidney Int 100: 502–505, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Adragao T, Ferreira A, Frazao JM, Papoila AL, Pinto I, Monier-Faugere MC, et al.: Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients. PLoS One 12: e0179868, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Marques ID, Araújo MJ, Graciolli FG, Reis LM, Pereira RM, Custódio MR, et al.: Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int 28: 1675–1683, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Ferreira AC, Mendes M, Silva C, Cotovio P, Aires I, Navarro D, et al.: Bone densitometry versus bone histomorphometry in renal transplanted patients: A cross-sectional study. Transpl Int 34: 1065–1073, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    Pimentel A, Bover J, Elder G, Cohen-Solal M, Ureña-Torres PA: The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)—A systematic review. Diagnostics (Basel) 11: 772, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust MH, et al.; European Renal Osteodystrophy (EUROD) workgroup; an initiative of the CKD-MBD working group of the ERA-EDTA; and the committee of Scientific Advisors and National Societies of the IOF: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: A call for a shift from nihilism to pragmatism. Osteoporos Int 32: 2397–2405, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al.: Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med 387: 299–309, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 242 242 68
Full Text Views 246 246 18
PDF Downloads 332 332 25